Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma × Folfox protocol × Clear all

Sponsor

Conditions

Colorectal Neoplasms 21 Rectal Neoplasms 10 Colonic Neoplasms 6 Pancreatic Neoplasms 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Adenocarcinoma Of Esophagus 3 Peritoneal Neoplasms 2 Neoplasms 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Neuropathy, Painful 1 Neuralgia 1 Neoplasm Recurrence, Local 1 Malignant Solid Tumour 1 Locally Advanced Pancreatic Carcinoma(LAPC) 1 Esophageal Squamous Cell Carcinoma 1 Cold Hypersensitivity 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Advanced Rectal Cancer 1 Advanced Primary Liver Cancer 1 Adenocarcinoma of the Lower Rectum 1

Interventions

Carboplatin 23 Cisplatin 19 pembrolizumab 13 Paclitaxel 12 Gemcitabine 12 Pemetrexed 11 130-nm albumin-bound paclitaxel 9 Everolimus 8 Cetuximab 8 Fluorouracil 7 Axitinib 6 osimertinib 5 durvalumab 5 Sunitinib 5 Radiotherapy 5 Erlotinib Hydrochloride 5 Docetaxel 5 Cyclophosphamide 5 Albumin-Bound Paclitaxel 5 Sorafenib 4 Radiation 4 Nivolumab 4 Ipilimumab 4 vosaroxin 3 Radiotherapy, Intensity-Modulated 3 Octreotide 3 Irinotecan 3 Bevacizumab 3 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 3 pralsetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡